Le Lézard
Classified in: Health
Subject: SVY

General and Pelvic Endoscopic Surgery Devices Markets, 2019 - Focus on US, France, Germany, Italy, Spain, the UK, Japan & RoW


DUBLIN, Aug. 23, 2019 /PRNewswire/ -- The "General and Pelvic Endoscopic Surgery Devices" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

This report provides an in-depth analysis of the global market for medical devices used in endoscopic general and pelvic surgeries.

Endoscopic medical devices covered in this market analysis include:

Markets covered include the US, the five major EU markets (France, Germany, Italy, Spain, the UK), Japan, and the rest of the world.

This report provides the following useful information:

Key Questions Answered:

Highlights:

  1. Approximately 25 million general and pelvic endoscopy procedures were performed worldwide in 2018; these included general endoscopy, OB/GYN, and urologic endoscopy procedures.
  2. The global market for general and pelvic endoscopic surgery products totaled approximately $13bn in 2018, and is expected to climb at a CAGR of 6.4% over the forecast period covered by this analysis.
  3. Within the combined market, hand instruments accounted for approximately 53% of sales in 2018.
  4. Leading competitors in the market for general and pelvic endoscopic surgery products include Ethicon/Johnson & Johnson, Medtronic, and Olympus, among others

Key Topics Covered:

Executive Summary
i. Global market
ii. Methodology

1. General and Pelvic Endoscopic Surgery Procedures

1.1 General endoscopic surgical procedures
1.2 Obstetric/gynecologic surgical procedures
1.3 Urologic surgery procedures
1.4 Bibliography

2. General and Pelvic Endoscopic Surgery Products

2.1 Access devices
2.1.1 Types of access devices
2.1.2 Products
2.2 Insufflation products
2.2.1 Products
2.3 Endoscopes
2.3.1 Types of endoscopes
2.3.2 Products
2.4 Endoscopic hand instruments
2.4.1 Products
2.5 Ancillary endoscopic surgery devices
2.5.1 Products
2.6 Endoscopic access site closure devices
2.6.1 Types of endoscopic access site closure products
2.6.2 Products
2.7 Bibliography

3. Endoscopy Access Devices Market
3.1 Market forecast: worldwide
3.1.1 Competitive analysis: worldwide
3.2 Market forecast: US
3.2.1 Competitive analysis: US
3.3 Market forecast: five major EU markets
3.3.1 Competitive analysis: five major EU markets
3.4 Market forecast: Japan
3.4.1 Competitive analysis: Japan
3.5 Market forecast: rest of the world
3.5.1 Competitive analysis: rest of the world
3.6 Bibliography

4. Insufflation Products Market

4.1 Market forecast: worldwide
4.1.1 Competitive analysis: worldwide
4.2 Market forecast: US
4.2.1 Competitive analysis: US
4.3 Market forecast: five major EU markets
4.3.1 Competitive analysis: five major EU markets
4.4 Market forecast: Japan
4.4.1 Competitive analysis: Japan
4.5 Market forecast: rest of the world
4.5.1 Competitive analysis: rest of the world
4.6 Bibliography

5. Endoscopes Market

5.1 Market forecast: worldwide
5.1.1 Competitive analysis: worldwide
5.2 Market forecast: US
5.2.1 Competitive analysis: US
5.3 Market forecast: five major EU markets
5.3.1 Competitive analysis: five major EU markets
5.4 Market forecast: Japan
5.4.1 Competitive analysis: Japan
5.5 Market forecast: rest of the world
5.5.1 Competitive analysis: rest of the world
5.6 Bibliography

6. Endoscopic Hand Instruments Market

6.1 Market forecast: worldwide
6.1.1 Competitive analysis: worldwide
6.2 Market forecast: US
6.2.1 Competitive analysis: US
6.3 Market forecast: five major EU markets
6.3.1 Competitive analysis: five major EU markets
6.4 Market forecast: Japan
6.4.1 Competitive analysis: Japan
6.5 Market forecast: rest of the world
6.5.1 Competitive analysis: rest of the world
6.6 Bibliography

7. Ancillary Endoscopic Devices Market

7.1 Market forecast: worldwide
7.1.1 Competitive analysis: worldwide
7.2 Market forecast: US
7.2.1 Competitive analysis: US
7.3 Market forecast: five major EU markets
7.3.1 Competitive analysis: five major EU markets
7.4 Market forecast: Japan
7.4.1 Competitive analysis: Japan
7.5 Market forecast: rest of the world
7.5.1 Competitive analysis: rest of the world
7.6 Bibliography

8. Endoscopic Access Site Closure Devices Market

8.1 Market forecast: worldwide
8.1.1 Competitive analysis: worldwide
8.2 Market forecast: US
8.2.1 Competitive analysis: US
8.3 Market forecast: five major EU markets
8.3.1 Competitive analysis: five major EU markets
8.4 Market forecast: Japan
8.4.1 Competitive analysis: Japan
8.5 Market Forecast: rest of the world
8.5.1 Competitive analysis: rest of the world
8.6 Bibliography

For more information about this report visit https://www.researchandmarkets.com/r/1lae8b

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 02:05
RedHill to receive $30 million following closing to support its commercial operations, including the planned launch of Talicia® this quarter and the ongoing promotion of Aemcolo® RedHill will receive an additional $50 million to fund the acquisition...

at 02:05
RedHill Biopharma Ltd. ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on the commercialization and development of proprietary drugs for...

at 02:00
February 25, 2020 Company provides update related to coronavirus disease 2019 (COVID-19) outbreak Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today published its Annual Report 2019, and expects to...

at 02:00
Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), announces the expansion of its aseptic filling capacity and capabilities with the addition of a new, fully robotic filling line....

at 01:39
Elekta (EKTA-B.ST) invites analysts and investors to a meeting on April 4, in conjunction with the Annual Meeting of the European Society for Radiation Oncology (ESTRO), in Vienna, Austria. The investor meeting will be held on Saturday, April 4, at...

at 01:35
Regulatory News: Lysogene (Paris:LYS) (FR0013233475 ? LYS), a pioneering Phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track...



News published on 23 august 2019 at 10:45 and distributed by: